☆ 4.2 Meeting Abstract

Adaptation of HIV-1 to the human immune system at the population level is driven by protective HLA-B alleles

RETROVIROLOGY (2009)

Journal

RETROVIROLOGY

Volume 6, Issue -, Pages -

Publisher

BIOMED CENTRAL LTD

DOI: 10.1186/1742-4690-6-S3-O41

Keywords

-

Categories

Virology

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

Article Immunology

Immune escape pathways from the HBV core18-27 CD8 T cell response are driven by individual HLA class I alleles

Andreas Walker, Tatjana Schwarz, Janine Brinkmann-Paulukat, Karin Wisskirchen, Christopher Menne, Elahe Salimi Alizei, Helenie Kefalakes, Martin Theissen, Daniel Hoffmann, Julian Schulze zur Wiesch, Mala K. K. Maini, Markus Cornberg, Anke R. M. Kraft, Verena Keitel, Hans H. H. Bock, Peter A. A. Horn, Robert Thimme, Heiner Wedemeyer, Falko M. M. Heinemann, Tom Luedde, Christoph Neumann-Haefelin, Ulrike Protzer, Joerg Timm

Summary: This study performed a high-resolution analysis of the core(18-27) specific CD8+ T cell and the selected escape pathways in patients with chronic HBV infection. The results demonstrate the promiscuous presentation of the core(18-27) epitope and the selection pressure on the epitope in the context of different HLA class I molecules. Some epitope variants showed evidence for impaired antigen processing and reduced presentation. These findings suggest the importance of considering epitope variants in T cell-based therapy strategies for chronic HBV infection.

FRONTIERS IN IMMUNOLOGY (2022)

Add to Collection

Article Immunology

Association of HLA-DPA1, HLA-DPB1, and HLA-DQB1 Alleles With the Long-Term and Booster Immune Responses of Young Adults Vaccinated Against the Hepatitis B Virus as Neonates

Wen-Chang Wang, Yu-Shiang Lin, Yin-Fan Chang, Chih-Ching Yeh, Chien-Tien Su, Jin-Shang Wu, Fu-Hsiung Su

Summary: In this study, HLA-DPA1 was primarily associated with the long-term response of primary infantile HBVac, while HLA-DPB1 and HLA-DQB1 exhibited associations with the HBV booster vaccination.

FRONTIERS IN IMMUNOLOGY (2021)

Add to Collection

Article Virology

Immunological Control of HIV-1 Disease Progression by Rare Protective HLA Allele

Yu Zhang, Takayuki Chikata, Nozomi Kuse, Hayato Murakoshi, Hiroyuki Gatanaga, Shinichi Oka, Masafumi Takiguchi

Summary: This study found that specific T cells restricted by the rare protective allele HLA-B*67:01 are associated with immune control of HIV-1. Some specific T cells targeting conserved or cross-reactive epitopes contribute to good clinical outcomes.

JOURNAL OF VIROLOGY (2022)

Add to Collection

Article Immunology

HLA-B13, B35 and B*39 Alleles Are Closely Associated With the Lack of Response to ART in HIV Infection: A Cohort Study in a Population of Northern Brazil

Leonn Mendes Soares Pereira, Eliane dos Santos Franca, Iran Barros Costa, Erika Vanessa Oliveira Jorge, Patricia Jeanne de Souza Mendonca Mattos, Amaury Bentes Cunha Freire, Francisco Luzio de Paula Ramos, Talita Antonia Furtado Monteiro, Olinda Macedo, Rita Catarina Medeiros Sousa, Eduardo Jose Melo dos Santos, Felipe Bonfim Freitas, Igor Brasil Costa, Antonio Carlos Rosario Vallinoto

Summary: Immune reconstitution failure after HIV treatment may be associated with a single polymorphism of human leukocyte antigen (HLA), particularly in the B locus, in patients from the Brazilian Amazon.

FRONTIERS IN IMMUNOLOGY (2022)

Add to Collection

Article Immunology

Protective HLA alleles against severe COVID-19: HLA-A*68 as an ancestral allele in Mexico

Susana Hernandez-Dono, Roberto Alejandro Sanchez-Gonzalez, Ma Guadalupe Trujillo-Vizuet, Fabiola Yeseline Zamudio-Castellanos, Rafael Garcia-Silva, Pedro Bulos-Rodriguez, Carlos A. Vazquez-Guzman, Ximena Cardenas-Ramos, Diana de Leon Rodriguez, Fabiola Elias, Sergio Dominguez-Arrevillaga, Jose Manuel Perez-Tirado, Olga Lidia Vera-Lastra, Julio Granados, Jesus Sepulveda-Delgado

Summary: This study investigated the association between HLA alleles and the severity of COVID-19 in Tapachula, Chiapas, Mexico. The results showed that HLA-A*68 and HLA-DRB1*03 may have a protective effect against severe infection and fatal outcome. However, the low frequency of HLA-DRB1*03 in the population limited the statistical power. The study suggests that the severity and fatal outcome of COVID-19 patients in this region depend more on the lack of resistance HLA alleles.

CLINICAL IMMUNOLOGY (2022)

Add to Collection

Article Genetics & Heredity

HLA Diversity in Saudi Population: High Frequency of Homozygous HLA Alleles and Haplotypes

Aziz Alami Chentoufi, F. Aytuel Uyar, Hiba A. Chentoufi, Khalid Alzahrani, Maria Paz, Ahmed Bahnassy, Ghaleb Elyamany, Assem Elghazaly

Summary: This retrospective study analyzed the levels of homozygosity in HLA class I and II alleles and haplotypes in the Saudi population, revealing a low genetic diversity. This has significant implications for transplantation practices, graft versus host disease prevention strategies, and host-pathogen interactions.

FRONTIERS IN GENETICS (2022)

Add to Collection

Article Immunology

Protective HLA Alleles Recruit Biased and Largely Similar Antigen-Specific T Cell Repertoires across Different Outcomes in HIV Infection

Dan Koning, Esther D. Quakkelaar, Ingrid M. M. Schellens, Eric Spierings, Debbie van Baarle

Summary: CD8(+) T cells play a significant role in controlling untreated HIV infection. HLA-B*27 and B*57 are associated with delayed HIV disease progression, but the specific factors providing superior immunity against HIV are unclear. This study found that there were no differences in TCR diversity between progressors and slow progressors, and both HLA alleles recruited biased T cell repertoires. These findings suggest that progressors and slow progressors have highly similar T cell repertoires in terms of TCR diversity, usage, and cross-reactivity.

JOURNAL OF IMMUNOLOGY (2022)

Add to Collection

Review Biochemistry & Molecular Biology

Protective HLA-B57: T cell and natural killer cell recognition in HIV infection

Christian A. Lobos, Jonathan Downing, Lloyd J. D'Orsogna, Demetra S. M. Chatzileontiadou, Stephanie Gras

Summary: Understanding immune determinants controlling disease outcome is crucial for patient care and therapeutic development. HICs, a group of rare HIV+ individuals, can control the virus and maintain a low viral load without treatment, which is associated with the expression of HLA-B57 alleles. However, the specific immune response differences in HICs are still unclear.

BIOCHEMICAL SOCIETY TRANSACTIONS (2022)

Add to Collection

Article Multidisciplinary Sciences

Differing natural killer cell, T cell and antibody profiles in antiretroviral-naive HIV-1 viraemic controllers with and without protective HLA alleles

Ana Moyano, Bongiwe Ndlovu, Msizi Mbele, Kewreshini Naidoo, Nasreen Khan, Jaclyn. K. K. Mann, Thumbi Ndung'u

Summary: By studying the immune responses of HIV controllers, we found that there were no significant differences in the breadth and magnitude of CD8+ T cell responses between VC+ and VC-. However, NK cells and T cells from VC- group showed higher activation markers and more terminally differentiated profiles. Additionally, VC- group exhibited a trend of more potent neutralizing antibody responses. These findings suggest that VC+ and VC- may control HIV infection through different immune response mechanisms.

PLOS ONE (2023)

Add to Collection

Article Multidisciplinary Sciences

HLA alleles and haplotypes in Sudanese population and their relationship with Mediterraneans

Fabio Suarez-Trujillo, Sayda El-Safi, Ignacio Juarez, Jose Palacio-Gruber, Alejandro Sanchez-Orta, Jose Manuel Martin-Villa, Antonio Arnaiz-Villena

Summary: A study on Sudanese HLA found that Nubians in Sudan are genetically related to Sub-Saharan populations in Africa, while other Sudanese tribes are closer to Mediterranean populations. This suggests the existence of prehistoric genetic and peoples exchange between Africa and the Mediterranean basin.

SCIENTIFIC REPORTS (2023)

Add to Collection

Article Immunology

Association of specific HLA alleles and haplotypes with pemphigus vulgaris in the Bulgarian population

Kossara Drenovska, Milena Ivanova, Snejina Vassileva, Martin Abu Shahid, Elissaveta Naumova

Summary: This study analyzed the role of genetic factors in the development of pemphigus vulgaris (PV) in Bulgaria. The results revealed certain HLA alleles that are associated with susceptibility to PV, as well as alleles that are protective against autoimmune diseases. These findings help explain the higher incidence and clinical variability of the disease in certain populations.

FRONTIERS IN IMMUNOLOGY (2022)

Add to Collection

Article Genetics & Heredity

TLR agonists enhance responsiveness of inflammatory innate immune cells in HLA-B*57-positive HIV patients

L. Dold, L. Zimmer, C. Schwarze-Zander, C. Boesecke, R. Mohr, J. -C. Wasmuth, K. Ommer, B. Gathof, B. Kraemer, J. Nattermann, C. P. Strassburg, J. K. Rockstroh, U. Spengler, B. Langhans

Summary: HLA-B*57 affects the course of HIV infection by modifying inflammatory subsets of NK cells and monocytes, leading to enhanced responsiveness of these innate immune cells to TLR ligands, potentially contributing to increased vulnerability in sepsis.

JOURNAL OF MOLECULAR MEDICINE-JMM (2021)

Add to Collection

Review Medicine, General & Internal

HLA-DPB1 alleles in hepatitis B vaccine response A meta-analysis

Guojin Ou, Xiaojuan Liu, Yongmei Jiang

Summary: This meta-analysis reveals that specific HLA-DPB1 alleles are significantly associated with an increased antibody response to the HB vaccine, further elucidating the role of genetic factors in this immune response.

MEDICINE (2021)

Add to Collection

Article Genetics & Heredity

Association of Protective HLA-A With HLA-B*27 Positive Ankylosing Spondylitis

Jessika Nordin, Mats Pettersson, Lina Hultin Rosenberg, Argyri Mathioudaki, Asa Karlsson, Eva Muren, Karolina Tandre, Lars Ronnblom, Alf Kastbom, Jan Cedergren, Per Eriksson, Peter Soderkvist, Kerstin Lindblad-Toh, Jennifer R. S. Meadows

Summary: This study investigated the role of MHC in ankylosing spondylitis through typing 17 genes, identifying 25 HLA protein-coding variants associated with the disease. Novel protective associations were found in a HLA-B*27 positive population, and unique risk variants were identified in different sexes, highlighting the impact of population composition on disease associations.

FRONTIERS IN GENETICS (2021)

Add to Collection

Editorial Material Cell Biology

Two new HLA alleles, HLA-B18:200 and HLA-C04:435 detected in Russian donors

Maria Loginova, Daria Smirnova, Svetlana Kutyavina, Igor Paramonov, Andrey Belyaev

Summary: Two novel alleles, HLA-B*18:200 and HLA-C*04:435, have been characterized in this study.

HLA (2021)

Add to Collection

Article Immunology

Similar Risk of Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Similar Nucleocapsid Antibody Levels in People With Well-Controlled Human Immunodeficiency Virus (HIV) and a Comparable Cohort of People Without HIV

Myrthe L. Verburgh, Anders Boyd, Ferdinand W. N. M. Wit, Maarten F. Schim van der Loeff, Marc van der Valk, Margreet Bakker, Neeltje A. Kootstra, Lia van der Hoek, Peter Reiss

Summary: In the Amsterdam-based AGE(h)IV Cohort Study, researchers prospectively compared the incidence and risk factors for SARS-CoV-2 infection between HIV-positive and HIV-negative participants. They found that HIV-positive individuals with suppressed viremia and adequate CD4 cell counts had similar risk of SARS-CoV-2 acquisition and similar post-infection nucleocapsid antibody levels compared to a comparable HIV-negative cohort.

JOURNAL OF INFECTIOUS DISEASES (2022)

Add to Collection

Article Neurosciences

Correlation between cerebrospinal fluid and plasma neurofilament light protein in treated HIV infection: results from the COBRA study

Jasmini Alagaratnam, Davide De Francesco, Henrik Zetterberg, Amanda Heslegrave, Jamie Toombs, Neeltje A. Kootstra, Jonathan Underwood, Magnus Gisslen, Peter Reiss, Sarah Fidler, Caroline A. Sabin, Alan Winston

Summary: In PWH on suppressive antiretroviral treatment, there is a moderate correlation between CSF and plasma NfL, similar to lifestyle-similar HIV-negative individuals. Consideration of renal function and bodyweight may be required when utilizing plasma NfL.

JOURNAL OF NEUROVIROLOGY (2022)

Add to Collection

Article Medicine, General & Internal

Immunogenicity and Reactogenicity of Vaccine Boosters after Ad26.COV2.S Priming

Roos S. G. Sablerolles, Wim J. R. Rietdijk, Abraham Goorhuis, Douwe F. Postma, Leo G. Visser, Daryl Geers, Katharina S. Schmitz, Hannah M. Garcia Garrido, Marion P. G. Koopmans, Virgil A. S. H. Dalm, Neeltje A. Kootstra, Anke L. W. Huckriede, Melvin Lafeber, Debbie van Baarle, Corine H. GeurtsvanKessel, Rory D. de Vries, P. Hugo M. van der Kuy

Summary: This study investigated the immunogenicity and reactogenicity of a homologous or heterologous booster in healthcare workers who had received a single-shot Ad26.COV2.S vaccine. The results showed that booster vaccinations increased the levels of S-specific binding antibodies, neutralizing antibodies, and T-cell responses compared to a single Ad26.COV2.S vaccination. Boosters containing mRNA-based vaccines induced significantly higher levels of binding antibodies than homologous boosters. The mRNA-1273 booster was the most immunogenic but had higher reactogenicity compared to the BNT162b2 and Ad26.COV2.S boosters. Local and systemic reactions were generally mild to moderate in the first 2 days after booster administration.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

Add to Collection

Article Hematology

Quantitative analysis of mRNA-1273 COVID-19 vaccination response in immunocompromised adult hematology patients

Sabine Haggenburg, Birgit Lissenberg-Witte, Rob S. van Binnendijk, Gerco den Hartog, Michel S. Bhoekhan, Nienke J. E. Haverkate, Dennis M. de Rooij, Johan van Meerloo, Jacqueline Cloos, Neeltje A. Kootstra, Dorine Wouters, Suzanne S. Weijers, Ester M. M. van Leeuwen, Hetty J. Bontkes, Saida Tonouh-Aajoud, Mirjam H. M. Heemskerk, Rogier W. Sanders, Elianne Roelandse-Koop, Quincy Hofsink, Kazimierz Groen, Lucia Cetinel, Louis Schellekens, Yvonne M. den Hartog, Belle Toussaint, Iris M. J. Kant, Thecla Graas, Emma de Pater, Willem A. Dik, Marije D. Engel, Cheyenne R. N. Pierie, Suzanne R. Janssen, Edith van Dijkman, Meliawati Poniman, Judith A. Burger, Joey H. Bouhuijs, Gaby Smits, Nynke Y. Rots, Sonja Zweegman, Arnon P. Kater, Tom van Meerten, Pim G. N. J. Mutsaers, Jaap A. van Doesum, Annoek E. C. Broers, Marit J. van Gils, Abraham Goorhuis, Caroline E. Rutten, Mette D. Hazenberg, Inger S. Nijhof

Summary: Vaccination guidelines for hematological patients are typically conservative. However, this study shows that most patients, even those with compromised immune systems, can develop sufficient antibody concentrations after receiving the Moderna vaccine. However, certain treatments may affect the vaccine's efficacy.

BLOOD ADVANCES (2022)

Add to Collection

Article Gastroenterology & Hepatology

A Prospective Five-Year Follow-up After peg-Interferon Plus Nucleotide Analogue Treatment or no Treatment in HBeAg Negative Chronic Hepatitis B Patients

Robin Erken, Vladimir V. Loukachov, Annikki de Niet, Louis Jansen, Femke Stelma, Jeltje T. Helder, Martine W. Peters, Hans L. Zaaijer, Neeltje A. Kootstra, Sophie B. Willemse, Hendrik W. Reesink

Summary: In this study, long-term follow-up of patients with chronic hepatitis B was conducted, and it was found that combination treatment did not influence the disappearance of HBsAg, while low baseline HBsAg levels could predict HBsAg loss.

JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY (2022)

Add to Collection

Letter Gastroenterology & Hepatology

Untitled Reply

Vladimir V. Loukachov, Karel A. van Dort, Robin Erken, Henk W. Reesink, Neeltje A. Kootstra

HEPATOLOGY (2022)

Add to Collection

Article Immunology

Identification of Liver and Plasma microRNAs in Chronic Hepatitis B Virus infection

Vladimir V. Loukachov, Karel A. van Dort, Irma Maurer, R. Bart Takkenberg, Anniki de Niet, Henk W. Reesink, Sophie B. Willemse, Neeltje A. Kootstra

Summary: This study identified differentially expressed miRNAs in the plasma and liver of patients with CHB. Plasma miRNAs may be useful as biomarkers for treatment outcome or viral activity during treatment, while liver miRNAs are more likely to be regulated by HBV and could be potential therapeutic targets to control viral activity in liver.

FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2022)

Add to Collection

Article Immunology

Anti-HIV-1 Nanobody-IgG1 Constructs With Improved Neutralization Potency and the Ability to Mediate Fc Effector Functions

Angela I. Schriek, Marlies M. van Haaren, Meliawati Poniman, Gillian Dekkers, Arthur E. H. Bentlage, Marloes Grobben, Gestur Vidarsson, Rogier W. Sanders, Theo Verrips, Teunis B. H. Geijtenbeek, Raimond Heukers, Neeltje A. Kootstra, Steven W. de Taeye, Marit J. van Gils

Summary: Broadly neutralizing nanobodies targeting HIV-1 envelope glycoprotein, combined with IgG1 Fc fusion, have been studied as alternative treatments. The study found that multivalent nanobodies coupled with long linkers showed increased neutralization potency. Fusion of IgG1 Fc domain to nanobodies not only improved neutralization potency but also restored Fc-mediated antibody effector functions.

FRONTIERS IN IMMUNOLOGY (2022)

Add to Collection

Article Immunology

Durability of Immune Responses After Boosting in Ad26.COV2.S-Primed Healthcare Workers

Roos S. G. Sablerolles, Wim J. R. Rietdijk, Abraham Goorhuis, Douwe F. Postma, Leo G. Visser, Katharina S. Schmitz, Daryl Geers, Susanne Bogers, Eva van Haren, Marion P. G. Koopmans, Virgil A. S. H. Dalm, Neeltje A. Kootstra, Anke L. W. Huckriede, Renate Akkerman, Martin Beukema, Melvin Lafeber, Debbie van Baarle, Rory D. de Vries, P. Hugo M. van der Kuy, Corine H. GeurtsvanKessel

Summary: This study found that SARS-CoV-2-specific binding antibodies, neutralizing antibodies, and T cells remained detectable 5 months after boosting with Ad26.COV2.S vaccine, although there was a decline in antibody levels and limited cross-reactivity with Omicron BA.1.

CLINICAL INFECTIOUS DISEASES (2023)

Add to Collection

Letter Gastroenterology & Hepatology

Reply

Vladimir Loukachov, Karel van Dort, Robin Erken, Henk W. Reesink, Neeltje Kootstra

HEPATOLOGY (2023)

Add to Collection

Article Immunology

The effect of SARS-CoV-2 vaccination on post-acute sequelae of COVID-19 (PASC): A prospective cohort study

Elke Wynberg, Alvin X. Han, Anders Boyd, Hugo D. G. van Willigen, Anouk Verveen, Romy Lebbink, Karlijn van der Straten, Neeltje Kootstra, Marit J. van Gils, Colin Russell, Tjalling Leenstra, Menno D. de Jong, Godelieve J. de Bree, Maria Prins

Summary: A prospective study found that vaccination did not significantly improve symptoms in patients with PASC, and there was no difference in antibody decay rates between PASC and non-PASC patients.

VACCINE (2022)

Add to Collection

Article Virology

Identification of a Novel HBV Encoded miRNA Using Next Generation Sequencing

Vladimir Loukachov, Karel A. van Dort, Louis Jansen, Henk W. Reesink, Neeltje A. Kootstra

Summary: A novel Hepatitis B Virus (HBV) encoded miRNA, HBV-miR-6, was identified and validated in liver tissue from chronic hepatitis B (CHB) patients. Its expression was correlated with hepatic HBV-DNA and plasma HBsAg levels, suggesting a potential role in viral excretion or particle formation.

VIRUSES-BASEL (2022)

Add to Collection

Article Immunology

Leukocyte Count and Coronary Artery Disease Events in People With Human Immunodeficiency Virus: A Longitudinal Study

Emma F. Avery, Julia N. Kleynhans, Bruno Ledergerber, Isabella C. Schoepf, Christian W. Thorball, Neeltje A. Kootstra, Peter Reiss, Lene Ryom, Dominique L. Braun, Maria C. Thurnheer, Catia Marzolini, Marco Seneghini, Enos Bernasconi, Matthias Cavassini, Helene Buvelot, Roger D. Kouyos, Jacques Fellay, Huldrych F. Guenthard, Philip E. Tarr

Summary: In Switzerland, leukocyte count is independently associated with coronary artery disease (CAD) events in people with HIV (PWH), even after adjusting for traditional and HIV-related risk factors.

CLINICAL INFECTIOUS DISEASES (2023)

Add to Collection

Meeting Abstract Immunology

Older people with well-controlled HIV have similar antibody and higher T-cell responses after vaccination against SARS-CoV-2 compared to demographically and lifestyle-comparable people without HIV

M. Verburgh, L. van Pul, M. Grobben, A. Boyd, F. Wit, A. van Nuenen, K. van Dort, K. Tejjani, J. van Rijswijk, M. Bakker, L. van der Hoek, M. Schim van der Loeff, M. van der Valk, M. van Gils, N. Kootstra, P. Reiss

JOURNAL OF THE INTERNATIONAL AIDS SOCIETY (2022)

Add to Collection

Meeting Abstract Pharmacology & Pharmacy

Immunogenicity 5-months after homologous or heterologous booster vaccination in Health Care Workers primed with Ad26.COV2.S

R. Sablerolles, W. Rietdijk, A. Goorhuis, D. Postma, L. Visser, M. Koopmans, V Dalm, N. Kootstra, A. Huckriede, M. Lafeber, D. van Baarle, C. GeurtsvanKessel, R. de Vries, H. van der Kuy

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2022)

Add to Collection

No Data Available

© Peeref 2019-2024. All rights reserved.